Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, CA / ACCESSWIRE / April 15, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today...
Day: April 15, 2022
ESO Releases 2022 ESO Fire Service Index to Explore Key Trends and Measures Affecting Fire Departments Across the Country
Index looks at response time, structures involved in fires, property loss and decontamination AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading data and...
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GAITHERSBURG, Md., April 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a leading commercial cell-engineering company...
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday,...
2022 first quarter : Income increase by 55%
Press Release Ecully, April 15, 2022 – 10 am Continued growth in Q1 2022Q1 2022 revenues up +55% In thousands of...
Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced...
EssilorLuxottica: Leadership changes announced at GrandVision
Leadership changes announced at GrandVision Charenton-le-Pont, France, and Schiphol, The Netherlands (April 15, 2022 – 8 am CET) – EssilorLuxottica...
Koelis Announces Completes of €10 Million Follow-On Growth Equity Financing with InnovaHealth Partners
GRENOBLE, France and PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”) announced today the...
LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market
PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing...
Sienna Announces First Quarter 2022 Results Release Date and Conference Call
MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that...
Christina Lake Cannabis Corp. Files Financial Statements for the Year Ended November 30, 2021
VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- (CSE: CLC) -- Christina Lake Cannabis Corp. (the “Corporation or “Christina...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022
Monthly information regarding the total number of voting rights and total number of shares of the Company as...
Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022
MIAMI BEACH, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel...
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
PONTE VEDRA, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company...
Vor Bio Announces Retirement of Chief Medical Officer
CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...
LianBio Announces Formation of Scientific Advisory Board
Scientific Advisory Board strengthens LianBio’s mission of bringing novel therapeutics to Greater China and AsiaSHANGHAI, China and PRINCETON, N.J., April...
Sight Sciences to Report First Quarter 2022 Financial Results on May 10, 2022
MENLO PARK, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on...
Eledon to Host Virtual R&D Day on Thursday, April 28, 2022
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company...
Angion Announces Participation in Upcoming Investment Conference
UNIONDALE, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development,...